Although KMTs were initially studied for their causative role in hematological malignancies resulting from KMT2A rearrangements, we know today that KMT2C and KMT2D are the most frequently mutated among the human cancer genes [160,170,171,172]. This evidence concerns the gene KMT2A and cancer.